Screening for "Prelysosomal Disorders": Carbohydrate-Deficient Glycoprotein Syndromes

Journal of Child Neurology - Tập 14 Số 1_suppl - Trang S16-S22 - 1999
Marc C. Patterson1
1Departments of Neurology and Pediatric and Adolescent Medicine, Mayo Clinic and Foundation, Rochester, MN, [email protected]

Tóm tắt

Physicians have become accustomed to thinking of certain inborn errors of metabolism (eg, lysosomal, peroxisomal, and mitochondrial diseases) as being associated with specific subcellular organelles. In recent years, a family of disorders of N-glycosylation has been recognized, in which the metabolic defect is expressed in the cytosol, endoplasmic reticulum, and Golgi apparatus. These could be conveniently thought of as "prelysosomal" disorders. At least six of these entities are characterized by hypoglycosylation of many glycoconjugates, and have been designated as the carbohydrate-deficient glycoprotein syndromes. Given the ubiquity of the products of N-glycosylation in the cellular economy, it is not surprising that these defects in metabolism have protean clinical manifestations. Delayed development and other neurologic symptoms are wedded to variable dysfunctions of the heart, liver, and endocrine and coagulation systems. Patients can have dysmorphic features or cerebellar hypoplasia, attesting to the antenatal expression of these disorders. The most frequently recognized phenotype (several hundred cases worldwide) has been designated carbohydrate-deficient glycoprotein syndrome type 1a, and results from mutations in phosphomannomutase, a cytosolic enzyme involved in the synthesis of the lipid-linked oligosaccharide that is eventually attached to nascent glycoproteins through the amide group of asparagine residues. All forms of carbohydrate-deficient glycoprotein syndrome express an excess of hypoglycosylated isoforms of circulating transferrin, which serves as a useful screening tool. Physicians should consider screening for carbohydrate-deficient glycoprotein syndrome in individuals with delayed development, seizures, strokelike episodes, cerebellar hypoplasia, and demyelinating neuropathy with or without other signs of multisystem disease. (J Child Neurol 1999;14(Suppl 1):S16-S22).

Từ khóa


Tài liệu tham khảo

10.1007/BF00714272

10.1172/JCI110189

10.1073/pnas.87.19.7443

10.1093/hmg/8.3.523

10.1093/glycob/3.2.97

Sabatini DD, Adesnik MB: The biogenesis of membranes and organelles, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Molecular and Metabolic Bases of Inherited Disease, vol 1. New York, McGraw-Hill, 1995, pp 459-553.

10.1203/00006450-198002000-00117

10.1016/0009-8981(84)90059-7

1991, Acta Pediatr Scand, 375, 1

10.1016/0387-7604(94)00099-J

1997, Eur J Pediatr Neurol, 2, 61

10.1111/j.1651-2227.1993.tb12517.x

10.1111/j.1651-2227.1997.tb14917.x

10.1203/00006450-199611000-00017

10.1016/0140-6736(93)91244-G

10.1016/0014-5793(95)01357-1

1996, Am J Hum Genet, 59, 810

10.1172/JCI2266

10.1073/pnas.95.22.13200

10.1055/s-2008-1071513

10.1055/s-2007-979762

10.1023/A:1005351927573

10.1136/jmg.34.1.73

1996, J Inherit Metab Dis, 19, 6

10.1038/ng0597-88

10.1093/hmg/7.2.157

10.1172/JCI2350

10.1006/bbrc.1998.8385

1998, J Inherit Metab Dis, 21, 96

1998, J Inherit Metab Dis, 21, 97

10.1136/jnnp.57.5.552

10.1111/j.1651-2227.1995.tb13720.x

1995, J Clin Endocrinol Metab, 80, 3744

10.1007/s002560050335

10.1097/00001721-199603000-00003

10.1002/(SICI)1096-8652(199901)60:1<66::AID-AJH11>3.0.CO;2-D

Thông tin
Thông tin xuất bản

Journal of Child Neurology

Tập 14 Số 1_suppl

S16-S22

Thông tin tác giả